News
Eli Lilly will acquire gene-editing startup Verve Therapeutics for up to $1.3 billion, the companies said on Tuesday, to ...
(Reuters) -Drugmaker Eli Lilly is in advanced talks to acquire gene-editing startup Verve Therapeutics for up to $1.3 billion ...
AstraZeneca PLC has acquired a significant stake of 15.86% in Niox Group PLC, according to a recent company filing. This move ...
Under terms of the deal, CSPC will receive $110 million upfront, with potential milestone payments reaching up to $5.22 ...
17h
Zacks.com on MSNAstrazeneca (AZN) Stock Falls Amid Market Uptick: What Investors Need to KnowAstrazeneca (AZN) concluded the recent trading session at $73.55, signifying a -1.17% move from its prior day's close.
NodThera Announces Appointment of Elisabeth Björk as Board Member Former SVP at AstraZeneca R&D brings deep expertise in ...
An AI approach developed by researchers from the University of Sheffield and AstraZeneca, could make it easier to design ...
Cambridge headquartered global pharmaceutical company AstraZeneca took its spending on China plays in the last month to ...
The pending deal was rumored overnight after a report from the Financial Times, spurring analysts to speculate that if true, ...
AstraZeneca PLC closed 19.20% below its 52-week high of £133.88, which the company achieved on September 3rd.
Another Cambridge UK life science company has expanded its trade reach into China as a new Silk Road of trade re-opens.
Building the future of health care: the need for investment in radiopharmaceutical commercialization
The efforts of CNIC and CMIE are setting the stage for this future, ensuring that Canada remains at the cutting edge of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results